News

While performing heart bypass surgery, SPY-Q enables cardiac surgeons using Novadaq’s SPY imaging system to objectively measure increases in fluorescence by comparing pre- and post-bypass images, the company

The approval is based on data from two large, pivotal Phase III, multi-center, randomized, double-blind, placebo controlled trials, Phoenix 1 & 2, involving nearly 2,000 patients in whom

The non-exclusive agreement provides Biogenuix with the rights to distribute in India. Among the standardized RT-PCR (StaRT-PCR) based research molecular tools are kits for chronic myelogenous leukemia, lung

The drug candidate is an antimicrobial peptide named plectasin NZ2114 that targets the treatment of severe infections, such as pneumonia and septicaemia, caused by bacteria like Staphylococcus and

Pursuant to the memorandum of understanding (MoU), Pharmaceutics International (PII) will promote the NexACT technology to its clients and may independently identify new product development opportunities for this

Prior to joining QRxPharma, Mr Soriano was senior director of business development at Osiris Therapeutics and responsible for all business development activities, including IP strategy and operations, out-licensing

Matthias M. Baltisberger, Site Head Roche Basel, commented: “The location for an investment is not chosen for sentimental reasons. So an important criterion in selecting the site for

Teva and Lonza will co-operate to develop, manufacture and market a number of affordable, efficacious and safe generic equivalents of a selected portfolio of biologic pharmaceuticals. Through this

Initially the focus will be on five of BMI’s 56 hospitals – London, Central Manchester, Birmingham, Sheffield and Harrogate. SurgiCare said that it plans to add further hospitals